Retinol is the most evidence-backed anti-ageing active available without a prescription. The research goes back to the 1980s when Kligman and colleagues first documented topical vitamin A’s effects on photoaged skin – and the decades since have only refined the understanding of why it works so well.
Retinol itself is biologically inactive. After application, enzymes in the keratinocytes convert it first to retinaldehyde, then to retinoic acid (tretinoin) – the active form. Retinoic acid binds to nuclear receptors (RARs) and regulates gene transcription, affecting cell turnover rate, collagen synthesis, and the inhibition of matrix metalloproteinases (MMPs), which are the enzymes responsible for breaking down existing collagen.
The practical result: faster skin cell turnover, measurably increased collagen production, and reduced collagen degradation. A 2007 study in the Archives of Dermatology documented statistically significant improvements in fine wrinkles, mottled pigmentation, roughness, and skin laxity after 24 weeks of 0.4% retinol use.
The retinoid spectrum matters. From weakest to strongest OTC: retinyl esters (two conversion steps) – retinol (the benchmark) – retinaldehyde (one step from retinoic acid, roughly 11x more potent than retinol) – adapalene 0.1% (OTC in some markets, prescription-grade efficacy). Tretinoin requires a prescription and is the reference standard everything else is measured against.
Start two or three times per week at 0.025-0.05% and build up over four to six weeks. Applying to damp skin or over moisturiser slows absorption and reduces the adjustment period. The initial dryness and peeling is accelerated cell turnover, not damage. SPF the next morning is non-negotiable – retinol significantly increases photosensitivity.